Are you Dr. Levesque?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5889 Forbes Avenue, Suite 220
Pittsburgh, PA 15217Phone+1 412-586-3350Fax+1 412-386-3540
Summary
- Dr. Marc Levesque, MD is a rheumatologist in Pittsburgh, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Veterans Affairs Pittsburgh Healthcare System and is an Associate Professor at University of Pittsburgh School of Medicine.
Education & Training
- Duke University HospitalFellowship, Rheumatology, 1993 - 1998
- Duke University HospitalResidency, Internal Medicine, 1989 - 1992
- Yale School of MedicineClass of 1989
Certifications & Licensure
- PA State Medical License 2008 - 2022
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Fellow American College of Rheumatology
Clinical Trials
- Nitric Oxide, LPS and the Pathogenesis of Asthma Phase 1 Start of enrollment: 2003 May 01
- Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants Start of enrollment: 2009 Nov 01
Publications & Presentations
PubMed
- 200 citationsHigh-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies.Hua-Xin Liao, Marc C. Levesque, Ashleigh Nagel, Ashlyn Dixon, Ruijun Zhang
Journal of Virological Methods. 2009-06-01 - 42 citationsDifferential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarkerYong Gil Hwang, Goundappa K. Balasubramani, Ilinca D. Metes, Marc C. Levesque, S. Louis Bridges
Arthritis Research & Therapy. 2016-05-17 - 89 citationsCYTOKINE INDUCTION OF THE ABILITY OF HUMAN MONOCYTE CD44 TO BIND HYALURONAN IS MEDIATED PRIMARILY BY TNF-ALPHA AND IS INHIBITED BY IL-4 AND IL-13Marc C. Levesque, Barton F. Haynes
Journal of Immunology. 1997-12-15